相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
M. Caraglia et al.
CELL DEATH & DISEASE (2011)
Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science
Shinji Tanaka et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
Zhe Zhang et al.
BMC MEDICINE (2009)
Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation
Akinobu Taketomi et al.
TRANSPLANTATION (2009)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: An institute's experience with 625 patients
Akinobu Taketomi et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Clinical aspects of hepatocellular carcinoma in Japan
Kiwamu Okita
INTERNAL MEDICINE (2006)
Resection and liver transplantation for hepatocellular carcinoma
JM Llovet et al.
SEMINARS IN LIVER DISEASE (2005)
分享论文
